ArticleCureus2026
Survival Outcomes and Clinicopathologic Prognostic Factors in Gastric Cancer: A Small Single-Center Retrospective Cohort From Eastern Türkiye.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionReal-world data from eastern Türkiye regarding gastric cancer outcomes remain limited. We aimed to describe overall survival (OS) and explore associations between OS and key clinicopathologic factors in a small, single-center cohort.
methodsWe retrospectively reviewed consecutive adults with gastric adenocarcinoma who underwent gastrectomy with curative intent between January 2019 and June 2025. Perioperative mortality (<30 days) was excluded to focus on long-term oncologic outcomes. OS was defined from surgery to death from any cause; survivors were administratively censored at June 2, 2025. Kaplan-Meier methods and univariate Cox models were used.
resultsThirty patients were included (mean age 65.8±9.4 years; 20/30 male). Median follow-up among survivors was 19.2 months (IQR 8.2-30.8). Twelve- and 24-month OS were 71.1% and 62.2%, respectively; median OS was not reached. Median retrieved lymph nodes was 20 (IQR 19-36; range 4-61). Median lymph node ratio (LNR) was 0.09 (IQR 0.04-0.21). Older age showed a borderline association with worse OS in univariate Cox analysis.
conclusionsIn this small exploratory cohort, OS estimates were modest and associations with clinicopathologic variables were largely inconclusive due to limited power. Larger, multicenter cohorts with standardized reporting of histology, staging, and perioperative treatment are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.